Literature DB >> 9066090

The effects of testosterone on the cavernous tissue and erectile function.

R Shabsigh1.   

Abstract

A review of the current literature is conducted to explore the developmental aspects, animal and human experiences and the effects of pharmacological manipulation to explain the role androgens play in sexual function with special emphasis on erectile function and the erectile tissue. This review reveals that androgens are necessary for the normal development of the penis and their deficiency results in significant structural abnormalities. Although androgen receptors in the penis decrease after puberty, they usually do not disappear completely. Animal data show that androgens support erectile function through a direct effect on the erectile tissue. Experimental castration results in impaired erectile response to central and peripheral stimulation and decrease in penile tissue concentration of nitric oxide synthase-containing nerves. Testosterone replacement reverses these abnormalities. In the rat penis, apoptosis is induced by castration and new DNA synthesis is induced by testosterone replenishment. Human data are less clear than animal data. Castration results in loss of libido and in erectile dysfunction. However, these effects are not universal. Testosterone enhances libido, frequency of sexual acts and sleep-related erections. Its effects on erotic erections are not clear.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9066090     DOI: 10.1007/bf01275152

Source DB:  PubMed          Journal:  World J Urol        ISSN: 0724-4983            Impact factor:   4.226


  52 in total

1.  Androgenic regulation of gap junctions between motoneurons in the rat spinal cord.

Authors:  A Matsumoto; A P Arnold; G A Zampighi; P E Micevych
Journal:  J Neurosci       Date:  1988-11       Impact factor: 6.167

2.  Identification, partial characterization and age-related changes of a cytoplasmic androgen receptor in the rat penis.

Authors:  J Rajfer; P C Namkung; P H Petra
Journal:  J Steroid Biochem       Date:  1980-12       Impact factor: 4.292

3.  Induction of the TRPM-2 gene in cells undergoing programmed death.

Authors:  R Buttyan; C A Olsson; J Pintar; C Chang; M Bandyk; P Y Ng; I S Sawczuk
Journal:  Mol Cell Biol       Date:  1989-08       Impact factor: 4.272

4.  Androgen receptor levels in the rat penis are controlled differently in distinctive cell types.

Authors:  K K Takane; D A Husmann; M J McPhaul; J D Wilson
Journal:  Endocrinology       Date:  1991-05       Impact factor: 4.736

5.  Fetal phallic growth and penile standards for newborn male infants.

Authors:  K W Feldman; D W Smith
Journal:  J Pediatr       Date:  1975-03       Impact factor: 4.406

6.  High failure rate associated with long-term follow-up of neoadjuvant androgen deprivation followed by radical prostatectomy for stage C prostatic cancer.

Authors:  M L Cher; K Shinohara; S Breslin; J Vapnek; P R Carroll
Journal:  Br J Urol       Date:  1995-06

7.  Differential maintenance of penile responses and copulatory behavior by gonadal hormones in castrated male rats.

Authors:  R L Meisel; J K O'Hanlon; B D Sachs
Journal:  Horm Behav       Date:  1984-03       Impact factor: 3.587

8.  Impotence in medical clinic outpatients.

Authors:  M F Slag; J E Morley; M K Elson; D L Trence; C J Nelson; A E Nelson; W B Kinlaw; H S Beyer; F Q Nuttall; R B Shafer
Journal:  JAMA       Date:  1983-04-01       Impact factor: 56.272

9.  Differences in responsiveness to testosterone of penile reflexes and copulatory behavior of male rats.

Authors:  B L Hart; S J Wallach; P Y Melese-d'Hospital
Journal:  Horm Behav       Date:  1983-09       Impact factor: 3.587

10.  Testosterone receptors in corpora cavernosa of penis.

Authors:  C J Godec; H Bates; K Labrosse
Journal:  Urology       Date:  1985-09       Impact factor: 2.649

View more
  22 in total

1.  Penile apoptosis in association with p53 under lack of testosterone.

Authors:  Hiroto Yamamoto; Shoichi Sasaki; Hiroyuki Tatsura; Yukihiro Umemoto; Hiroki Kubota; Hiroyuki Kamiya; Tetsuya Kawai; Kiho Kang; Kenjiro Kohri
Journal:  Urol Res       Date:  2003-12-18

Review 2.  Therapy of erectile dysfunction: potential future treatments.

Authors:  Nestor F Gonzalez-Cadavid; Jacob Rajfer
Journal:  Endocrine       Date:  2004 Mar-Apr       Impact factor: 3.633

Review 3.  Physiology of penile erection and pathophysiology of erectile dysfunction.

Authors:  Robert C Dean; Tom F Lue
Journal:  Urol Clin North Am       Date:  2005-11       Impact factor: 2.241

Review 4.  Androgens and male aging: Current evidence of safety and efficacy.

Authors:  Louis J Gooren
Journal:  Asian J Androl       Date:  2010-02-15       Impact factor: 3.285

Review 5.  Translational Perspective on the Role of Testosterone in Sexual Function and Dysfunction.

Authors:  Carol A Podlasek; John Mulhall; Kelvin Davies; Christopher J Wingard; Johanna L Hannan; Trinity J Bivalacqua; Biljana Musicki; Mohit Khera; Nestor F González-Cadavid; Arthur L Burnett
Journal:  J Sex Med       Date:  2016-08       Impact factor: 3.802

6.  Androgen depletion in humans leads to cavernous tissue reorganization and upregulation of Sirt1-eNOS axis.

Authors:  Inês Tomada; Nuno Tomada; Henrique Almeida; Delminda Neves
Journal:  Age (Dordr)       Date:  2011-11-04

7.  Serum total testosterone level and identification of late-onset hypogonadism: a community-based study.

Authors:  Sungmin Kang; Hyun Jun Park; Nam Cheol Park
Journal:  Korean J Urol       Date:  2013-09-10

Review 8.  [Testosterone replacement therapy and prostate cancer. The current position 67 years after the Huggins myth].

Authors:  L Rinnab; K Gust; R E Hautmann; R Küfer
Journal:  Urologe A       Date:  2009-05       Impact factor: 0.639

Review 9.  Effect of androgens on penile tissue.

Authors:  Ronald W Lewis; Thomas M Mills
Journal:  Endocrine       Date:  2004 Mar-Apr       Impact factor: 3.633

10.  The benefits and risks of testosterone replacement therapy: a review.

Authors:  Nazem Bassil; Saad Alkaade; John E Morley
Journal:  Ther Clin Risk Manag       Date:  2009-06-22       Impact factor: 2.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.